Maravai LifeSciences Holdings, Inc. MRVI Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$230.76M+11.1% | -$259.62M-87.6% | -$138.38M-128% | $490.66M+4.6% | ||
| $23.56M+13.0% | $20.85M+61.7% | $12.9M+70.5% | $7.57M+18.0% | ||
| $30.17M-38.9% | $49.42M+42.9% | $34.59M+85.3% | $18.67M+78.5% | ||
| $84.6M-49.1% | $166.2M— | —— | $0— | ||
| —— | —— | —— | $22.27M— | ||
| -$8M-2,022% | -$377K— | —— | -$9.46M— | ||
| -$7.35M-1,116% | $723K-86.3% | $5.28M+435% | -$1.58M— | ||
| -$4.63M— | —— | —— | —— | ||
| -$1.63M— | —— | -$7.28M-120% | $36.38M+282% | ||
| -$18.63M-196% | -$6.3M+60.6% | -$15.98M-517% | $3.83M+185% | ||
| —— | —— | —— | $8.34M— | ||
| $27.95M+1.5% | $27.53M+0.6% | $27.36M+12.7% | $24.27M+32.3% | ||
| $8.96M+5.7% | $8.48M-0.5% | $8.53M+36.0% | $6.27M-28.7% | ||
| -$57.57M— | —— | $126.22M-76.4% | $535.98M+45.4% | ||
| $13.15M-55.7% | $29.66M-54.8% | $65.55M+284% | $17.09M+15.1% | ||
| —— | $0— | —— | —— | ||
| $0-100% | $1.8M— | $0— | —— | ||
| -$31.41M-29.2% | -$24.32M+80.1% | -$122.31M+54.3% | -$267.61M-340% | ||
| $5.44M-97.7% | $234.39M+4,209% | $5.44M-60.8% | $13.9M+132% | ||
| —— | —— | —— | —— | ||
| -$16.5M+93.0% | -$235.94M— | —— | -$187.5M-17.9% | ||
| —— | $0— | $0— | $0+100% | ||
| -$105.51M+60.0% | -$264.04M-362% | -$57.18M-171% | $80.87M-74.3% | ||
| $24.98M-51.0% | $50.97M+15.2% | $44.26M+119% | $20.2M-25.8% | ||
| -$561K-184% | $670K— | —— | $23.03M+2.5% | ||
| $27.95M+1.5% | $27.53M+0.6% | $27.36M+12.7% | $24.27M+32.3% | ||
| —— | $166.15M— | $0— | —— | ||
| $23.56M+13.0% | $20.85M+61.7% | $12.9M+70.5% | $7.57M+18.0% | ||
| -$18.63M-196% | -$6.3M+60.6% | -$15.98M-517% | $3.83M+185% | ||
| -$181K-18.3% | -$153K+82.2% | -$861K— | —— | ||
| -$1.63M— | —— | -$7.28M-120% | $36.38M+282% | ||
| $8.96M+5.7% | $8.48M-0.5% | $8.53M+36.0% | $6.27M-28.7% | ||
| —— | —— | —— | $8.34M— | ||
| $0-100% | $1.8M— | $0— | —— | ||
| -$10K-102% | $494K-94.9% | $9.61M— | —— | ||
| $0-100% | $7.11M-83.1% | $42.15M— | —— | ||
| —— | -$1.76M-401% | -$352K— | —— | ||
| —— | —— | —— | —— | ||
| —— | $0— | —— | $7.8M— | ||
| —— | —— | $0— | —— | ||
| -$561K-184% | $670K— | —— | $23.03M+2.5% | ||
| -$70.72M— | —— | —— | $518.89M+46.7% | ||
| -$70.72M— | —— | —— | $518.89M+46.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maravai LifeSciences Holdings, Inc. generate?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated -$39.5M in operating cash flow over the trailing twelve months.
- What is Maravai LifeSciences Holdings, Inc.'s free cash flow?
- After $13.1M of capital expenditures, Maravai LifeSciences Holdings, Inc.'s free cash flow was -$52.6M over the trailing twelve months, down 283.3% year over year.
- Where does Maravai LifeSciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
